168 related articles for article (PubMed ID: 36118668)
1. Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
Liu Z; Liu Q; Wang X; Liu L; Shi L; Li H
Dis Markers; 2022; 2022():6106503. PubMed ID: 36118668
[TBL] [Abstract][Full Text] [Related]
2. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
Yang L; Lu P; Yang X; Li K; Chen X; Qu S
Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
[TBL] [Abstract][Full Text] [Related]
3. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
Zhao G; Fu Y; Su Z; Wu R
Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.
Yang Y; Feng L; Wang R; Ma H; He S; Fang J
Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201
[TBL] [Abstract][Full Text] [Related]
5. Complex integrated analysis of lncRNAs-miRNAs-mRNAs in oral squamous cell carcinoma.
Li S; Chen X; Liu X; Yu Y; Pan H; Haak R; Schmidt J; Ziebolz D; Schmalz G
Oral Oncol; 2017 Oct; 73():1-9. PubMed ID: 28939059
[TBL] [Abstract][Full Text] [Related]
6. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
[TBL] [Abstract][Full Text] [Related]
7. Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma.
Qiu YL; Liu YH; Ban JD; Wang WJ; Han M; Kong P; Li BH
Oncol Rep; 2019 Feb; 41(2):895-907. PubMed ID: 30431131
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
11. Using RNA sequencing to identify a putative lncRNA-associated ceRNA network in laryngeal squamous cell carcinoma.
Lyu K; Li Y; Xu Y; Yue H; Wen Y; Liu T; Chen S; Liu Q; Yang W; Zhu X; Wang Z; Chai L; Wen W; Li C; Lei W
RNA Biol; 2020 Jul; 17(7):977-989. PubMed ID: 32174248
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
[TBL] [Abstract][Full Text] [Related]
13. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
[TBL] [Abstract][Full Text] [Related]
14. Exploring the long noncoding RNAs-based biomarkers and pathogenesis of malignant transformation from dysplasia to oral squamous cell carcinoma by bioinformatics method.
Jia H; Wang X; Sun Z
Eur J Cancer Prev; 2020 Mar; 29(2):174-181. PubMed ID: 31343435
[TBL] [Abstract][Full Text] [Related]
15. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
Wang M; Feng Z; Li X; Sun S; Lu L
Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
[TBL] [Abstract][Full Text] [Related]
16. Hub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis.
Lu J; Li R; Fang M; Ke S
Comput Math Methods Med; 2022; 2022():6027058. PubMed ID: 36238478
[TBL] [Abstract][Full Text] [Related]
17. Expression and mechanism of long non-coding RNA HCG22 in oral squamous cell carcinoma.
Gao YQ; Shi PW; Shi WK; Liu YM
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Dec; 39(6):658-666. PubMed ID: 34859625
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
Yang Y; Chen D; Liu H; Yang K
Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
[TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
